BSH 2017 | Whole genome sequencing in CLL
Anna Schuh, MD, PhD, from the University of Oxford, Oxford, UK discusses research into whole genome sequencing at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. Work has been done as part of the 100,000 genomes project with Genomics England, and the Department of Health, sequencing the whole genome, which may be more time effective and diagnostically useful.From the first sixty samples of the Chronic Lymphocytic Leukemia (CLL) pilot, clinically relevant findings, such as deletions and mutations of TP53 have been reliably reported. She states that hopefully, in the near future, whole genome sequencing will be introduced into routine diagnostics. This video has been supported by Napp Pharmaceuticals Ltd through an unrestricted educational grant to Magdalen Medical Publishing.
